Overview

Full Product Details

Author:   Dusko Ilic
Publisher:   Springer-Verlag New York Inc.
Imprint:   Springer-Verlag New York Inc.
Edition:   Softcover reprint of the original 1st ed. 2014
Dimensions:   Width: 15.50cm , Height: 1.00cm , Length: 23.50cm
Weight:   2.934kg
ISBN:  

9781493955602

ISBN 10:   1493955608
Pages:   168
Publication Date:   23 August 2016
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

1 Setting Quality Standards for Stem Cell Banking, Research and Translation: The International Stem Cell Banking Initiative.- 2 The Challenge of Standardisation in Stem Cell Research and Development.- 3 Global Perspective on Cord Blood Stem Cell Banking.- 4 Stem Cell Research and Banking: Towards Policy on Disclosing Research Results and Incidental Findings.- 5 The Legal Duties of Stem Cell Banks with Regards to Stem Cell Donors and Recipients.- 6 European Regulations and Ethical Issues on Cord Blood Banking.- 7 Donor Recruitment and Eligibility Criteria for HLA-Homozygous iPSC Bank in Japan.- 8 Banking of Pluripotent Stem Cells: Issues and Opportunities from the NIH Perspective.-  9 Sibling Donor Cord Blood Program: Children’s Hospital Research Center Oakland and Beyond.- 10 Anthony Nolan Experience: Issues and Strategy for Cord Blood Banking from Ethnic Minority Groups.- 11 Establishment of Mesenchymal Stem Cell Banks in India.- 12 Stem Cell Banking in Iran.- 13 Stem Cell Biobanks and Long-Term Sustainability: A Swiss Working Model.- 14 Establishing a Public Cord Blood Bank and Regulatory Framework in Parallel: a Serbian Example.

Reviews

Author Information

Dr. Dusko Ilic obtained his MD degree and BSci in Molecular Biology at the University of Belgrade, his PhD at the Tokyo University, Japan and he completed postdoctoral training at the University of California in San Francisco. Before joining King’s College School of Medicine in London, he held positions of Adjunct Associate Professor at the University of California San Francisco, Consultant at the Veteran Affairs Medical Center, San Francisco and as Director of R&D at StemLifeLine, a California-licensed stem cell company. Dr. Ilic's current research interests are human embryonic stem (hES) cells, induced pluripotent stem (iPS) cells, and mesenchymal stem cells and their potential in drug discovery and cell-based therapies.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions